2018 China SummIT of Probiota
Probiota is a group of microorganisms that are claimed to provide health benefITs when consumed. The introduction of the concept (but not the term) is generally attributed to Nobel laureate Élie Metchnikoff, who postulated that yogurt-consuming Bulgarian peasants lived longer lives because of this custom.
2018 International Symposium on Neonatal HeredITary Diseases and Translational Medicine
Monogenic diseases are frequent causes of neonatal morbidITy and mortalITy, and disease presentations are often undifferentiated at birth. More than 3500 monogenic diseases have been characterized, but clinical testing is available for only some of them and many feature clinical and genetic heterogeneITy.
2018 International SummIT Forum on Medical Materials
This forum contains four parallel meetings, which focuses on new biomedical materials, 3D-bioprinting, dental / oral materials, tissue repair and regeneration, orthopaedic materials, medical devices aiming to provide a platform for researchers in this field to communicate wITh each other, to promote international cooperation.
2018 Symposium on DigITal Pathology and Clinical Application
WITh the advent of Whole-Slide Imaging, the field of digITal pathology has exploded and is currently regarded as one of the most promising avenues of diagnostic medicine in order to achieve even better, faster and cheaper diagnosis, prognosis and prediction of cancer and other important diseases.
2018 Symposium on Cancer Evolution and HeterogeneITy
HeterogeneITy is a major challenge in cancer treatment, which has a profound impact on cancer evolution & metastasis and drug resistance. WITh the developments of new technologies, there emerge successive achievements wITh great significance on clinical therapeutics. This symposium will focus on cancer heterogeneITy, promoting the clinical translation of research.
2018 Forum on Next Generation High SensITivITy Testing Technology and Application
Including topics like liquid biopsy, microfluidics and exosomes, this forum will focus on basic research, clinical application, technology R&D as well as industrialization. Bioon's missions are to pave the way for discovery of new biomarkers and to facilITate developments of in vITro diagnostics ( IVD ) & early cancer detection!
2018 International Conference on Gene EdITing and Gene Therapy
Promoting the reasonable application and clinical translation of gene edITing technology iss of great importance. In addITion, there are many researchers and clinicians caring about progress of gene therapy. Therefore, Bioon is going to hold the 2018 International Conference on Gene EdITing and Gene Therapy, so as to improve exchange and cooperation among all sides.